FDA Approves Lebrikizumab-lbkz for Moderate to Severe Atopic Dermatitis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
POLL: When Do You Escalate AD Treatment if Treatment Targets are Not Achieved?
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Defining Photosensitivity in Atopic Dermatitis
Overcoming Therapeutic Inertia in Atopic Dermatitis—The AHEAD Recommendations as a Path Forward